Camosunate Children 1-6 Years: Pediatric Antimalarial Powder
Camosunate (1-6 years) is a highly effective Artemisinin-based Combination Therapy (ACT) used in Nigeria to treat acute, uncomplicated malaria in young children. It contains a balanced combination of Artesunate (50mg) and Amodiaquine (150mg), designed to eliminate malaria parasites quickly.
This formulation comes in a convenient granular powder form within sachets, specifically for children aged 1 to 6 years who may find it difficult to swallow tablets. The granules are vanilla-flavored to help your child take the medicine easily.
Camosunate 1 to 6 Years Dosage
The standard treatment for Camosunate is a 3-day course. Each pack contains 6 sachets, which are used as follows:
- Day 1: 2 sachets (1 pair) as a single dose.
- Day 2: 2 sachets (1 pair) as a single dose.
- Day 3: 2 sachets (1 pair) as a single dose.
It is critical to complete the full 3-day treatment even if your child feels better after the first day. This ensures all parasites are cleared from the blood. For children with specific weight concerns (generally 9kg to 18kg), please consult a GoMed pharmacist for precise advice.
How to Mix Camosunate Powder
To prepare the dose:
- Empty the contents of the required sachets into a clean cup.
- Add about 30ml (two tablespoons) of clean drinking water.
- Stir well until the powder is fully suspended.
- Administer immediately, preferably after a meal to minimize stomach upset.
Side Effects: What to Expect
Common side effects may include mild nausea, vomiting, or dizziness. Parents often ask how long camosunate side effects last; typically, these symptoms are temporary and resolve shortly after the treatment is completed. If you notice severe weakness or a persistent skin rash, stop use and contact a healthcare professional or a GoMed pharmacist immediately.
Price of Camosunate in Nigeria
The Camosunate price in Nigeria varies, but GoMed offers competitive rates with the convenience of doorstep delivery across major cities.
Camosunate is manufactured by Geneith Pharmaceuticals Ltd.